In summary, our study determined that DPSCs‐Exos contributed to the inhibition of HMGB1/TLR4/MyD88/NF‐κB pathway and alleviated the cerebral I/R damage (including brain oedema, cerebral infarction and neurological deficit) in mice after tMCAO. Here, MYD88 is linked to brain infarction.